Rosen Law Firm Nabs Lead In Biotech Investor's Drug Row
The Rosen Law Firm PA will represent a proposed class of investors in biotechnology company Longeveron Inc. in a suit accusing the company of overstating the prospects for a therapeutic product...To view the full article, register now.
Already a subscriber? Click here to view full article